These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


390 related items for PubMed ID: 28318634

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy.
    Jung E, Kim J, Ho Kim S, Kim S, Cho MH.
    Eur J Pharmacol; 2015 Aug 15; 761():116-24. PubMed ID: 25977232
    [Abstract] [Full Text] [Related]

  • 3. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
    Zhang M, Liu M, Xiong M, Gong J, Tan X.
    J Ethnopharmacol; 2012 May 07; 141(1):111-8. PubMed ID: 22353431
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC, Thallas-Bonke V, Banal C, Gray SP, Chow BS, Ramm G, Quaggin SE, Cooper ME, Schmidt HH, Jandeleit-Dahm KA.
    Diabetologia; 2016 Feb 07; 59(2):379-89. PubMed ID: 26508318
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. DNMT1-Mediated the Downregulation of FOXF1 Promotes High Glucose-induced Podocyte Damage by Regulating the miR-342-3p/E2F1 Axis.
    Chen JH, Ye L, Zhu SL, Yang Y, Xu N.
    Cell Biochem Biophys; 2024 Sep 07; 82(3):2957-2975. PubMed ID: 39014186
    [Abstract] [Full Text] [Related]

  • 11. Podocyte-specific knockin of PTEN protects kidney from hyperglycemia.
    Wang H, Feng Z, Xie J, Wen F, Jv M, Liang T, Li J, Wang Y, Zuo Y, Li S, Li R, Li Z, Zhang B, Liang X, Liu S, Shi W, Wang W.
    Am J Physiol Renal Physiol; 2018 Jun 01; 314(6):F1096-F1107. PubMed ID: 29361670
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
    Zhang Y, Ma KL, Liu J, Wu Y, Hu ZB, Liu L, Liu BC.
    Am J Physiol Endocrinol Metab; 2015 Jun 15; 308(12):E1140-8. PubMed ID: 25921580
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L, Fang J, Zhu B, Wang L, Chen J, Wang Y, Huang J, Wang H, Yao X.
    Life Sci; 2021 Mar 15; 269():119068. PubMed ID: 33476631
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.
    Advani A, Wiggins KJ, Cox AJ, Zhang Y, Gilbert RE, Kelly DJ.
    Nephrology (Carlton); 2011 Aug 15; 16(6):573-81. PubMed ID: 21342330
    [Abstract] [Full Text] [Related]

  • 17. LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin.
    Hu M, Wang R, Li X, Fan M, Lin J, Zhen J, Chen L, Lv Z.
    J Cell Mol Med; 2017 Nov 15; 21(11):2732-2747. PubMed ID: 28444861
    [Abstract] [Full Text] [Related]

  • 18. Sp1-mediated upregulation of Prdx6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis.
    Zhang Q, Hu Y, Hu JE, Ding Y, Shen Y, Xu H, Chen H, Wu N.
    Life Sci; 2021 Aug 01; 278():119529. PubMed ID: 33894270
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K, Raff AC, Schiffer M, Böttinger EP.
    Diabetes; 2006 Jan 01; 55(1):225-33. PubMed ID: 16380497
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.